Related Articles
Low expression of KCNN3 may affect drug resistance in ovarian cancer
Amplification of the NSD3‑BRD4‑CHD8 pathway in pelvic high‑grade serous carcinomas of tubo‑ovarian and endometrial origin
Downregulation of transient receptor potential cation channel, subfamily C, member 1 contributes to drug resistance and high histological grade in ovarian cancer
The core genes involved in the promotion of depression in patients with ovarian cancer
High IGF2 expression is associated with poor clinical outcome in human ovarian cancer